Patents Assigned to NeuronIcon ApS
  • MODULATION OF ACTIVITY OF PRONEUROTROPHINS
    Publication number: 20100210523
    Abstract: The present invention provides agents for inhibiting binding of a pro-neurotrophin to a Vps10p-domain receptor, in particular the binding of a pro-NGF or a pro-BDNF to a Sortilin receptor. The invention thus provides agents for the manufacture of a medicament, for treating and/or preventing disease or disorders such as but not limited to neurological, neuropsychiatric and ocular diseases, disorders, and degeneration as well as obesity, diabetes, pain and/or nociception in an individual.
    Type: Application
    Filed: December 21, 2007
    Publication date: August 19, 2010
    Applicant: NeuronIcon ApS
    Inventors: Olav Michael Andersen, Anders Nykjær